TrialEuropean journal of clinical pharmacology2017
Absolute oral bioavailability of selexipag, a novel oral prostacyclin IP receptor agonist.
Priska Kaufmann et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it